This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Innovator Spotlight: Shridhara C Murthy and His Impact on Vaccine Development
Introduction: Shridhara C Murthy, based in Ann Arbor, MI, is a noteworthy inventor in the field of vaccine technology. With a significant focus on the tetravalent rotavirus vaccine, he has made valuable contributions that enhance our understanding and application of genetic research in immunology.
Latest Patents: Shridhara C Murthy holds a patent for "Sequence analysis of the tetravalent rotavirus vaccine." This patent discloses isolated nucleic acid molecules that comprise a gene segment from a rhesus rotavirus (RRV) or from one of three rhesus-human reassortant viruses. Key aspects of this patent include isolated nucleic acid molecules featuring sequences from SEQ ID NO: 1-14, as well as those that encode proteins with sequences from SEQ ID NO: 15-28. Notably, this patent also encompasses variants of these isolated nucleic acid molecules, highlighting the innovative scope of his research.
Career Highlights: Shridhara C Murthy works under The United States of America, represented by the Secretary of the Department of Health and Human Services. His dedication to vaccine research positions him as a valuable contributor to public health and medical advancement. His sole patent underlines his expertise and innovative approach in the fight against contagious diseases.
Collaborations: Throughout his career, Shridhara has collaborated with other esteemed professionals, including Deborah A Buonagurio and Alice F Georgiu. These collaborations underscore the importance of teamwork in scientific research and the collective drive towards breakthroughs in health-related innovations.
Conclusion: Shridhara C Murthy's work exemplifies the critical role inventors play in public health advancements. Through his patent on the tetravalent rotavirus vaccine, he has contributed significantly to our understanding of viral genetics and vaccine development. His ongoing collaborations and research efforts continue to pave the way for innovative solutions in immunology.